More interestingly, EMT also plays a pivotal role in tumor immunosuppression and immune evasion, and the interplay between EMT and PD-L1 signaling contributes to therapeutic resistance of immune checkpoint blockade (ICB) [58, 59]. This evidence concerns the gene CD274 and neoplasm.